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Introduction. For pulmonary vein isolation in patients with atrial ﬁbrillation (AF), some centers use the double transseptal
puncture technique for catheter access in order to facilitate catheter manipulation within the left atrium. However, no safety
data has so far been published using this approach. Method. 269 ablation procedures were performed in 243 patients (mean age
56.6 ± 9.3 years, 75% men) using the double transseptal puncture for catheter access in all cases. Patients were considered for
ablation of paroxysmal (80%), persistent (19%), and permanent (1%) AF. 230 procedures were performed on an outpatient basis
(85.5%),and 26 were repeat procedures (9.7%).Results. The double transseptal puncture catheter access was successfully achieved
inall patients.The procedural success with theendpointofpulmonaryveinisolationwasreached in255procedures (95%).A total
of 1048 out of 1062 pulmonary veins (99%) were successfully isolated. Major complications occurred in eight patients (3.0%). Of
these, seven patients (2.6%) had pericardial eﬀusion requiring percutaneous drainage, and one patient (0.4%) suﬀered a minor
reversible stroke. One patient (0.4%) had a minor air embolism with transient symptoms. Conclusion. The double transseptal
puncture catheterization technique allows easy catheter manipulation within the left atrium to reach the goal of acute procedural
success in AF ablation. Procedure-related complications are rare, and the technique can be used safely for AF ablation in the
outpatient setting.
1.Introduction
Atrial ﬁbrillation (AF) is the most common of all cardiac
arrhythmias with an incidence and prevalence on the rise.
Radiofrequency catheter ablation is widely performed as an
eﬀective treatment for recurrent, drug-resistant AF [1–4].
Pulmonaryveinisolationguidedbycircumferentialmapping
is the cornerstone in the catheter ablation for AF [5, 6]. The
transseptal puncture is the conventional approach to access
the left atrium, which was initially developed and described
by Ross et al. for the measurement of left atrial pressure
and for mitral valve repair [7]. Recently, the technique is
routinely used in electrophysiologic laboratories in order
to percutaneously map and ablate left atrial arrhythmias,
especially AF [8].
When the electrophysiological or the combined electrical
and anatomic approach for the ablation of AF aims for
isolation of the pulmonary veins, two catheters have to be
introduced by the transseptal access into the left atrium for
mapping of the pulmonary veins and for radiofrequency
ablation,respectively.Thisisgenerallyachievedbythesingle-
puncture, double transseptal catheterization technique as a
second transseptal puncturecantheoretically bearadditional
risks inherent to the transseptal puncture, such as perfo-
ration resulting in pericardial tamponade, coronary artery
spasms provoked by mechanical irritation on the interatrial2 Cardiology Research and Practice
vagal network, air embolism, and thromboembolism [9].
Some centers use double transseptal puncture for catheter
access in order to facilitate catheter manipulation within the
left atrium and to avoid iatrogenic atrial septal defects [10].
Ablation techniques have improved and the complication
rate has decreased, but no safety data has so far been
published using the double transseptal puncture approach
[11–15].
2.Methods
2.1. Study Patients. Consecutive patients with symptomatic
paroxysmal and persistent AF undergoing a percutaneous
catheter ablation procedure at the Royal Jubilee Hospital
in Victoria BC (Canada) and at the University Hospi-
tal of Zurich (Switzerland) were included in this study.
Demographic and clinical data were collected prior to the
procedure. All patients gave informed consent prior to
the procedure. Clinical results at followup including late
complicationswerecollectedusingapatientassessment form
at 3 and 6 months after the intervention.
2.2. Double Transseptal Puncture. All patients underwent
wide-area circumferential pulmonary vein isolation. Addi-
tional linear lesions for persistent AF were applied in the left
atrium at the discretion of the operator. For that purpose,
three femoral vein sheaths were inserted under local anes-
thesia. A steerable decapolar electrophysiology catheter was
placed into the coronary sinus and a diagnostic quadripolar
catheter at the His bundle. The two separate transseptal
punctures were performed using a Brockenbrough transsep-
tal needle (Type BRK N◦1 ;S t .J u d eM e d i c a lI n c . ,S t .P a u l ,
MN, USA)and two 8F transseptal guiding introducers (Fast-
Cath SL1; St. Jude Medical Inc., St. Paul, MN, USA). The
ﬁrst 8F transseptal guiding introducer was placedin theright
femoralveinandadvancedoveraguidewireintothesuperior
vena cava under ﬂuoroscopic guidance. The guidewire
was replaced with the Brockenbrough needle which was
connected to a pressure curve line. Both Brockenbrough
needle and transseptal guiding sheath were withdrawn in
caudal direction keeping the needle and sheath hub arrow
rotated between 4 and 5 o’clock position under ﬂuoroscopic
guidance in 8◦ left anterior oblique projection until the
tip engaged the fossa ovalis. After the position was veriﬁed
within the fossa ovalis by ﬂuoroscopy in a 10◦ right anterior
obliqueprojection,anda15◦ leftanteriorobliqueprojection,
just the needle was advanced across the septum. After left
atrial pressure curve monitoring, aspiration of oxygenated
blood and contrast dye injection conﬁrmed the correct
needle tip position within the left atrium, the transseptal
assembly was advanced into the left atrium. For the second
transseptal puncture, the His mapping catheter was replaced
with a second 8F transseptal guiding introducer, which was
inserted into the left atrium by the same way as the ﬁrst
transseptal puncture.
Immediately after having positioned both transseptal
sheaths across the interatrial septum, therapeutic anticoag-
ulation was initiated with a bolus of intravenous heparin
NG
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Figure 1: Fluoroscopy image in anterior posterior view. Both the
ablationcatheterandthecircularmappingcatheterareinsertedinto
the left atrium and positioned at the ostium of the left superior
pulmonary vein after successful double transseptal puncture of
the interatrial septum. Esophageal position is monitored using
a contrast dye-ﬁlled nasogastric tube. ABL, ablation catheter;
LASSO,circularmappingcatheter;CS,coronarysinuscatheter;NG,
nasogastric tube.
(100IU/kg). Activated clotting time (ACT) was monitored
in 30-minute intervals followed by additional boluses of
heparintokeeptheACTwithatargetof300seconds. During
thetransseptal catheterization,continuousmonitoringofthe
electrocardiogramisperformed todetectanycoronaryartery
spasm provoked by the mechanical eﬀects of the transseptal
puncture on the interatrial vagal network or coronary
artery embolism, and monitoring of the cardiac silhouette
excursion on ﬂuoroscopy and monitoring of the systemic
blood pressure are performed to detect any impending
pericardial tamponade. A circular mapping catheter and
an ablation catheter were inserted through the transseptal
sheaths for mapping and ablation at the pulmonary vein
oriﬁce (Figure 1).
2.3. Oral Anticoagulation Strategy. Warfarin was discontin-
ued three days prior to the procedure to allow INR to drop
in a subtherapeutic range (INR < 2.0) on the day of the
procedure. Oral anticoagulation was resumed on the same
day of the procedure for a duration of at least 3 months
without bridging by low-molecular heparin.
2.4. Outpatient Setting for AF Ablation. The patients were
admittedtotheoutpatientfacilityonthemorningofthepro-
cedureandwerebroughttotheelectrophysiologiclaboratory
in a nonsedated state. The procedure was performed under
conscious sedation using midazolam and fentanyl. After the
sheaths were pulled out, the patients were monitored for
at least ﬁve hours and discharged if they were stable on
the same day. No routine echocardiogram was performed.Cardiology Research and Practice 3
The outpatient facility was staﬀed overnight and could
accommodate outpatient patients if overnight observation
and care were required [16].
3.Results
A total of 269 consecutive AF ablation procedures were
performed in 243 patients. The mean age of the study
population was 56.6 ± 9.3 years (75% male). The patient
characteristics are shown in Table 1. Of the 269 ablation
procedures, 230 were performed on an outpatient basis
(85.5%), whereas the remaining 39 patients (14.5%) were
kept overnight because of major complications (8 patients;
3%), or due to minor groin bleeding, late completion of the
procedure, prolonged sedation, or reduced well-being of the
patient. The analysis included 26 repeat ablation procedures
(9.7%). The procedural characteristics are shown in Table 2.
The double transseptal puncture techniques were per-
formed for left atrial catheter access using two separate
transseptalpuncturesthroughtwoseparatetransseptal holes,
rather than using the same hole of the ﬁrst transseptal
puncture. One patient required additional transesophageal
guidanceforthetransseptalpuncturesbecauseofdiﬃcultyto
cross the ﬁbrotic interatrial septum due to prior procedures.
In all cases, ablation catheter and circular mapping catheter
were easily manipulated within the left atrium and the acute
proceduralsuccesswiththeendpointofcompleteisolationof
all pulmonary veins was reached in 255 procedures (95%).
A total of 1048 out of 1062 pulmonary veins (98.7%) were
successfully isolated.
Major complications occurred in 7 outpatients and one
inpatient accounting for a combined incidence of 3.0%. Of
these, 7 patients (2.6%) had pericardial tamponade, which
was successfully drained percutaneously during or at the
end of the intervention in all cases. No delayed pericardial
tamponades were observed. One patient (0.4%) suﬀered
a minor reversible stroke with manifestation of numbness
in one hand. One patient (0.4%) had a minor reversible
air embolism with transient symptoms after passing the
sheaths through the interatrial septum. Another patient
(0.4%) had a typical Bezold-Jarish-like reﬂex with docu-
mentation of a sudden and transient ST-segment elevation
in the inferior leads, a phenomenon already reported as
coronary artery spasm provoked by mechanical irritation
by transseptal puncture of the interatrial vagal innervation
(Figure 2)[ 17]. There were neither acute nor late peripheral
or cerebral thromboembolic events. None of the procedures
were complicated by vascular access complications requiring
transfusion or surgical interventions.
4.Discussion
Catheter ablation of AF by pulmonary vein isolation can be
performed using twotransseptal catheters,onecircular map-
ping catheter and one ablation catheter, which are inserted
into the left atrium through either a single transseptal punc-
ture technique or by using separate transseptal punctures.
Table 1
Patient characteristics n = 243
Age (years) 56.6 ±9.3
Sex (male) 183 (75%)
Type of AF
Paroxysmal AF 195 (80.3%)
Persistent AF 45 (18.5%)
Permanent AF 3 (1.2%)
Duration of AF (years) 7.4 ±6.2
Left ventricular ejection fraction (%) 57.9 ±7.1
Left atrial diameter (mm) 43.3 ±5.4
Table 2
Procedural statistics n = 269
Average procedure time (min) 201 ± 31
Fluoroscopy time (min) 41.3 ±13.0
Major complications
(i) Thromboembolic event and stroke 1 (0.4%)
(ii) Pericardial tamponade 7 (2.6%)
(iii) Major vascular access complication
(requiring surgery or blood
transfusion)
none
Minor complications
(i) Reversible air embolism 1 (0.4%)
(ii) Bazold-Jarish-likereﬂex 1 (0.4%)
The transseptal puncture is a demanding procedure requir-
ing speciﬁc expertise related to the concern of the possible
occurrence of serious complications. Some centers perform
the single-puncture, double transseptal catheterization to
reduce the potential risk generated by a second transseptal
puncture, and others choose the doubletransseptal puncture
forcatheteraccessinordertofacilitatecathetermanipulation
within the left atrium. In this paper, we report the safety of
the double transseptal puncture for catheter access in a large
cohort of consecutive patients undergoing catheter ablation
of AF. The technique could be successfully performed in
all procedures, enabling easy catheter manipulation without
the catheters “sticking” to each other, which might occur
with the single-puncture, double transseptal catheterization
technique. This may explain that the procedural endpoint
of pulmonary vein isolation could be achieved for the vast
majority (98.7%) of the ablated pulmonary veins in our
patients.
Catheterablationon an outpatientbasis, which isalready
e s t a b l i s h e dt ob ef e a s i b l ea n ds a f ei nt h et r e a t m e n to f
supraventricular tachyarrhythmias, was also feasible in the
majority of patients in our cohort undergoing the double
transseptal puncture technique for catheter ablation of AF.
Same day discharge is an attractive model in light of
increasing numbers of AF ablation procedures leading to
logisticandhealth-economicalconstraints. Moreover,froma
patient’s perspective, outpatient procedure to early ambula-
tion increased patient comfort and early returnto work [18].4 Cardiology Research and Practice
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Figure 2: 12-lead ECG ofa patient with Bezold-Jarisch-likereﬂex. After passingthe catheters through the transseptalsheaths,a transientST
elevation was observed in leads II, III, and aVF, which resolved spontaneously after 5 minutes.
Our study showed that procedure-related complications are
rare, and the technique can be used safely for AF ablation in
the outpatient setting.
The incidence of major complications in our cohort was
comparable to that reported in the scientiﬁc literature for
AF ablation [19]. No acute major complication related to
the transseptal punctures was reported. Pericardial eﬀusion
requiring percutaneous drainage (2.6%) and the single
minor reversible cerebrovascular event (0.4%) manifested in
all patients close to the end or soon after completion of the
procedure,suggesting thatthese might be dueto the ablation
itself (longer procedure duration, multiple radiofrequency
energy applications, and prolonged catheter manipulation),
rather than the transseptal intervention while crossing the
interatrial septum.
Similar complication rates were reported by Fagundes
et al. in a retrospective patient cohort using a single-
puncture, double transseptal access for AF ablation [20].
In their cohort, no iatrogenic atrial septal defect was
detected during followup. In contrast to this observation,
the study of Hammerstingl et al. demonstrated a higher
incidence of long-term persistent iatrogenic atrial septal
defects after single transseptal puncture catheterization as
compared to those that occur after the double transseptal
puncture technique [10]. In 8 out of 27 patients who
underwent the single transseptal puncture with additional
advancement of a second catheter into the left atrium, an
iatrogenic atrial septal defect persisted compared with no
iatrogenic atrial septal defect in 15 patients using the double
transseptal puncture technique. Traumatic dilatation of the
single transseptal puncture by two catheters inserted into
the left atrium might result in severe endothelial denudation
promoting thrombosis and risk for thromboembolism as
shown by intracardiac ultrasound observation in another
study by Maleki et al. [21].
4.1. Study Limitations. This is an observational cohort study
and is not a prospective, randomized trial. In the absence of
a direct randomized comparison of the double transseptal
puncture technique versus the single transseptal puncture
access for the ablation of AF, limited conclusions regarding
superiority of one technique over the other in terms of
safety and procedural outcome can be made. In addition,
the clinical outcome was assessed based on symptoms
reported by the patients only, and therefore, the reliability
of the presented data on outcome is limited due to known
diﬃculties of survey-based studies.
5.Conclusion
The double transseptal puncture catheterization technique
allows easy catheter manipulation within the left atrium toCardiology Research and Practice 5
reach the goal of acute procedural success in AF ablation.
Procedure-related complications are rare and the technique
can be used for AF ablation in the outpatient setting.
However, it needs to be investigated in randomised studies
if the double transseptal puncture technique is superior to
thesingle-puncture,doubletransseptalcatheteraccessforAF
ablation in terms of safety and procedural success.
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